Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Rain Therapeutics Inc (was acquired by Pathos AI, Inc. (“Pathos”) on 13/12/2023) (RAIN)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 68
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Lucid Diagnostics Inc. (LUCD)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 73
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 63
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 67
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aclarion Inc (ACONW)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 71
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aclarion Inc (ACON)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 77
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Traws Pharma, Inc. (TRAW)

  • Technical Exchange News
  • Feb. 25, 2025, 18:49 UTC
  • 74
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lucid Diagnostics Inc. (LUCD)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 71
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 72
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 65
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 598
  • 599
  • 600
  • 601
  • 602
  • Next

Search

News categories

  • Technical Exchange News(14356)
  • Event(6229)
  • SEC News(372912)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(228629)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin